Consolidated Cash Flow Statement - USD ($) $ in Millions	12 Months Ended
	Nov. 30, 2025	Nov. 30, 2024	Nov. 30, 2023
Operating activities
Net income	$ 789.4	$ 788.5	$ 680.6
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	231.3	208.8	199.3
Stock-based compensation	46.2	47.4	63.4
Loss on the sale of a business	0.0	0.0	1.2
(Gain) loss on sale of assets	0.0	(2.1)	0.2
Deferred income tax benefit	(6.5)	(30.3)	(5.4)
Income from unconsolidated operations	(72.2)	(74.2)	(56.4)
Changes in operating assets and liabilities (net of effect of businesses acquired and disposed)
Trade accounts receivable	(14.7)	(20.5)	3.4
Inventories	23.9	(125.0)	225.0
Trade accounts payable	1.2	135.1	(68.1)
Other assets and liabilities	(94.2)	(72.6)	109.0
Dividends received from unconsolidated affiliates	57.8	66.8	85.1
Net cash flow provided by operating activities	962.2	921.9	1,237.3
Investing activities
Acquisition of business	(34.1)	0.0	0.0
Proceeds from sale of business	0.0	0.0	1.0
Capital expenditures (including software)	(221.8)	(274.9)	(263.9)
Other investing activities	0.7	5.9	2.4
Net cash flow used in investing activities	(255.2)	(269.0)	(260.5)
Financing activities
Short-term borrowings (repayments), net	(101.4)	211.1	(964.6)
Long-term debt borrowings	2.7	495.5	496.4
Payment of debt issuance costs	0.0	(1.0)	(1.1)
Long-term debt repayments	(267.9)	(801.1)	(268.1)
Proceeds from exercised stock options	20.9	17.5	16.6
Taxes withheld and paid on employee stock awards	(13.2)	(9.0)	(10.8)
Common stock acquired by purchase	(34.8)	(53.1)	(35.7)
Dividends paid	(483.0)	(451.0)	(418.5)
Other financing activities	35.8	8.0	1.6
Net cash flow used in financing activities	(840.9)	(583.1)	(1,184.2)
Effect of exchange rate changes on cash and cash equivalents	43.7	(50.3)	40.0
Increase (decrease) in cash and cash equivalents	(90.2)	19.5	(167.4)
Cash and cash equivalents at beginning of year	186.1	166.6	334.0
Cash and cash equivalents at end of year	$ 95.9	$ 186.1	$ 166.6